Press release
Global North America and Europe PEGylated Drugs Market | Key Players: Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau
North America and Europe PEGylated Drugs Market
Market Overview:
Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period.
Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth. Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511
Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.
Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.
Monoclonal antibodies are anticipated to witness over 12% CAGR over the coming years due to its wide-ranging applications such as, anti-PEG antibodies are used to quantitate numerous PEGylated compounds. Additionally, anti-PEG antibodies can be combined with compound specific to antibody to generate specific and sensitive assays.
Regional Analysis:
Canada PEGylated drugs market will witness over 5.5% CAGR from 2018 to 2024. Increasing prevalence of chronic ailments such as cancer will drive the business growth. As per Canadian Cancer Society, more than two lac people are diagnosed with cancer in 2017 that will surge demand for pegylated drugs in the future. Development and availability of various pegylated drugs including Onivyde, Plegridy, Oncaspar and others for treatment of several chronic ailments are factors accelerating business growth over the forecast timeframe.
Italy PEGylated drugs market was USD 218 million in 2017 and is anticipated to witness 9% CAGR over the coming few years. Increasing usage of peg-interferons for the treatment of Hepatitis C and soaring adoption of PEG-IFN beta-1a injectables for the treatment of patients with multiple sclerosis will foster market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511
Key Players:
Few notable industry players operating in North America and Europe PEGylated drugs market are Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau, Biogen, Pfizer and Roche. Industry players attempt to develop enhanced and effective PEGylated drugs for treating chronic conditions. Robust pipeline and ongoing research studies coupled with high R&D investment in PEGylation technology is anticipated to propel industry growth.
North America & Europe PEGylated Drugs Market by Disease Indication
Cancer
Hepatitis
Multiple sclerosis
Gastrointestinal disorders
North America & Europe PEGylated Drugs Market by Type
Monoclonal antibodies (mAbs)
Colony stimulating factors
Interferons
Chapter 3. North America & Europe PEGylated Drugs Industry Insights
3.1. Industry segmentation
3.2. Industry impact forces
3.2.1. Growth drivers
3.2.1.1. Increasing prevalence of cancer in developed regions
3.2.1.2. Rising R&D spending by biotechnology & pharmaceutical companies in U.S. and Europe
3.2.1.3. Growing biologics sector in the developed economies
3.2.2. Industry pitfalls & challenges
3.2.2.1. Drug recalls in the U.S. & Europe
3.2.2.2. Adverse drug reactions
3.3. Growth potential analysis
3.3.1. By disease indication
3.3.2. By type
3.4. Regulatory landscape
3.4.1. U.S.
3.4.2. Europe
3.5. Porter's analysis
3.6. Pipeline analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global North America and Europe PEGylated Drugs Market | Key Players: Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau here
News-ID: 1284021 • Views: …
More Releases from Global Market Insights, Inc.
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products.
Prenatal vitamin ingredients can…
More Releases for PEGylated
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market
Global PEGylated Proteins Market: Forecast by…
PEGylated Proteins Market Striking over 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market : Industry Perspective and Comprehensive Analysis 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market to See Incredible Growth
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
Segment-level analysis On PEGylated Proteins Market
Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021.
The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.…
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
